FOS and cancer: These complexes can either activate or repress transcription depending on the composition of the complex (e.g., Jun-Jun, Jun-Fos, Jun-ATF3), the promoter type, and the cell type, and can therefore act as either tumor suppressors or oncogenes in various cancer types.